Α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Synthesis of C-5″ and C-6″-Modified Α-GalCer Analogues as iNKT-cell Agonists

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2015English

Molecular Imaging of Cell-Based Cancer Immunotherapy

Molecular BioSystems
BiotechnologyMolecular Biology
2011English

Dendritic Cell-Based Immunotherapy for Prostate Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
1999English

IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2015English

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Therapeutic Strategy for Cancer Immunotherapy in Head and Neck Cancer

Advances in Cellular and Molecular Otolaryngology
2015English

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

Journal of Immunology
AllergyImmunology
2001English

Dendritic Cell-Based Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy